Funder
Center for Innovations in Quality, Effectiveness and Safety
Veterans Administration Medical Center, Yale School of Medicine
Health Services Research and Development
Reference81 articles.
1. The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017;Lancet Gastroenterol Hepatol,2020
2. The incidence and prevalence of paediatric- and adult-onset inflammatory bowel disease in Denmark during a 37-year period: a nationwide cohort study (1980-2017);Dorn-Rasmussen;J Crohns Colitis,2023
3. Canadian Gastro-Intestinal Epidemiology Consortium (CanGIEC). forecasting the incidence and prevalence of inflammatory bowel disease: a Canadian nationwide analysis;Coward;Am J Gastroenterol,2024
4. Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): determining therapeutic goals for treat-to-target;Peyrin-Biroulet;Am J Gastroenterol,2015
5. Early biologic treatment versus conventional treatment for the management of Crohn’s disease: a review of comparative clinical effectiveness and cost-effectiveness;Thompson,2019